Immunotherapy Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer Vaccine
Livin may be a major breast cancer antigen
February 8th, 2006
Livin may be a major breast cancer antigen. According to a study from Japan, "Survivin and livin are highly expressed in cancer cells and transformed cells, but show little or no expression in normal differentiated tissues. Human antibody responses to tumor-associated antigens have been detected, but little is known about the response to survivin and livin in breast cancer patients. We examined the prevalence of anti-survivin and livin antibodies in breast cancer patients with a specific enzyme-linked immunosorbent assay (ELISA) using recombinant protein." "Using a cutoff value for positivity determined as the mean absorbance +2SD for healthy control...
Source: Immunotherapy Weekly (2006-02-08)
|
